Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)

Grazia Daniela Femminella, Eleni Frangou, Sharon B. Love, Gail Busza, Clive Holmes, Craig Ritchie, Robert Lawrence, Brady McFarlane, George Tadros, Basil H. Ridha, Carol Bannister, Zuzana Walker, Hilary Archer, Elizabeth Coulthard, Ben R. Underwood, Aparna Prasanna, Paul Koranteng, Salman Karim, Kehinde Junaid, Bernadette McGuinness, Ramin Nilforooshan, Ajay Macharouthu, Andrew Donaldson, Simon Thacker, Gregor Russell, Naghma Malik, Vandana Mate, Lucy Knight, Sajeev Kshemendran, John Harrison, David J. Brooks, Anthony Peter Passmore, Clive Ballard, Paul Edison

Open source

DOI: 10.1186/s13063-019-3259-x
Published: 2019-04-03
Container: Trials
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13063-019-3259-x,
  title = {Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)},
  author = {Grazia Daniela Femminella and Eleni Frangou and Sharon B. Love and Gail Busza and Clive Holmes and Craig Ritchie and Robert Lawrence and Brady McFarlane and George Tadros and Basil H. Ridha and Carol Bannister and Zuzana Walker and Hilary Archer and Elizabeth Coulthard and Ben R. Underwood and Aparna Prasanna and Paul Koranteng and Salman Karim and Kehinde Junaid and Bernadette McGuinness and Ramin Nilforooshan and Ajay Macharouthu and Andrew Donaldson and Simon Thacker and Gregor Russell and Naghma Malik and Vandana Mate and Lucy Knight and Sajeev Kshemendran and John Harrison and David J. Brooks and Anthony Peter Passmore and Clive Ballard and Paul Edison},
  year = {2019},
  journal = {Trials},
  doi = {10.1186/s13063-019-3259-x},
  url = {https://doi.org/10.1186/s13063-019-3259-x}
}

RIS

TY  - JOUR
TI  - Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
AU  - Grazia Daniela Femminella
AU  - Eleni Frangou
AU  - Sharon B. Love
AU  - Gail Busza
AU  - Clive Holmes
AU  - Craig Ritchie
AU  - Robert Lawrence
AU  - Brady McFarlane
AU  - George Tadros
AU  - Basil H. Ridha
AU  - Carol Bannister
AU  - Zuzana Walker
AU  - Hilary Archer
AU  - Elizabeth Coulthard
AU  - Ben R. Underwood
AU  - Aparna Prasanna
AU  - Paul Koranteng
AU  - Salman Karim
AU  - Kehinde Junaid
AU  - Bernadette McGuinness
AU  - Ramin Nilforooshan
AU  - Ajay Macharouthu
AU  - Andrew Donaldson
AU  - Simon Thacker
AU  - Gregor Russell
AU  - Naghma Malik
AU  - Vandana Mate
AU  - Lucy Knight
AU  - Sajeev Kshemendran
AU  - John Harrison
AU  - David J. Brooks
AU  - Anthony Peter Passmore
AU  - Clive Ballard
AU  - Paul Edison
PY  - 2019
JO  - Trials
DO  - 10.1186/s13063-019-3259-x
UR  - https://doi.org/10.1186/s13063-019-3259-x
ER  -

APA

Femminella, G. D., Frangou, E., Love, S. B., Busza, G., Holmes, C., Ritchie, C., Lawrence, R., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E., Underwood, B. R., Prasanna, A., Koranteng, P., Karim, S., Junaid, K., McGuinness, B., Nilforooshan, R., Macharouthu, A., Donaldson, A., Thacker, S., Russell, G., Malik, N., Mate, V., Knight, L., Kshemendran, S., Harrison, J., Brooks, D. J., Passmore, A. P., Ballard, C., & Edison, P. (2019). Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study). Trials. https://doi.org/10.1186/s13063-019-3259-x

Source records

crossref · retrieved 2026-09-26T12:55:40.762Z